Melatonin and lipid uptake by murine fibroblasts: Clinical implications

Neuroendocrinology Letters

Volumn 27, Issue 5, 2006, Pages 601-608

  Maldonado, Maria D ^a   Siu, Andrew W ^b   Sánchez Hidalgo, Marina ^a   Acuna Castroviejo, Dario ^c   Escames, Germaine ^c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

^c UNIVERSITY OF GRANADA   (Spain)

Author keywords

Fibroblasts; Lipid accumulation; Melatonin; Oleic acid

Indexed keywords

FAT DROPLET; LIPID; LUZINDOLE; MELATONIN; MELATONIN RECEPTOR; MEMBRANE RECEPTOR; OLEIC ACID;

ANIMAL CELL; ARTICLE; CELL LINE; CELL STIMULATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CULTURE MEDIUM; DRUG RECEPTOR BINDING; FIBROBLAST; IN VITRO STUDY; LIPID METABOLISM; LIPID STORAGE; LIPID TRANSPORT; MOUSE; NONHUMAN; STAINING;

EID: 33846012914     PISSN: 0172780X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (53)

1. Imamura M, Inoguchi T, Ikuyama S, Taniguchi S, Kobayashi K, Nakashima N, Nawata H. ADRP stimulates lipid accumulation and lipid droplet formation in murine fibroblast. Am J Physiol Endocrinol Metab. 2002; 283:775-783.
2. Kaplan nM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceremia, and hypertension: Arch Intern Med. 1989; 149:1514-1520.
3. Kabn BB, Flier JS. Obesity and insulin resistance. J Clin Invest. 2000; 106:473-481.
4. Yeh S-S, Schuster MV. Geriatric cachexia: the role of cytokines. Am J Clin Nutr. 1999; 0:183-197.
5. Koumas L, Smith TJ, Feldon S, Blumberg N and Phipps RP. Thy-1 Expression in Human Fibroblast Subsets Defines Myofibrobastic or Lipofibrobastic Phenotypes. American Journal of Pathology. 2003; 163:1291-1300.
6. Tricoire H, Locatelli A, Chemineau P, Malpaux B. Melatonin enters the cerebrospinal fluid through the pineal recess. Endocrinology. 2002; 143:84-90.
7. Reiter JR. Melatonin: clinical relevance. Best Pract Res Clin Endocrinol Metab. 2003; 17:273-285.
8. Reiter JR, Tan DX. Melatonin reducing intracellular hostilities. The Endocrinologist. 2004; 14:222-228.
9. Reiter JR, Tan DX, Maldonado MD. Melatonin as an antioxidant: physiology versus pharmacology. J Pineal Res. 2005; 39:215-216.
10. Reiter JR, Tan DX, Gitto E, Sainz RM, Mayo JM, León J, Manchester LC, Kilic E, Kilic U. Pharmacological utility of melatonin in reducing oxidative cellular and molecular damage. Pol. J. Pharmacol. 2005; 56:159-170.
11. Tan DX, Chen LD, Poeggeler B, Manchester LC, Reiter RJ. Melatonin: a potent endogenous hydroxyl radical scavenger. Endocr J. 1993; 1:57-60.
12. Barrenetxe J, Delagrange P, Martinez JA. Physiologycal and metabolic functions of melatonin. J Physiol Biochem. 2004; 60:61-72.
13. Carrillo-Vico A, Calvo JR, Abreu P, Lardone PJ, Garcia-Maurino S, Reiter JR, Guerrero JM. Evidence of melatonin synthesis by human lymphocytes and its physiological significance: possible role as intracrine, autocrine, and/or paracrine substance. FASEB J. 2004; 18:537-539.
14. Nonno R, Fraschini F, Stankov BM. Methods for the evaluation of drug action at the human melatonin receptor subtypes. Biol Signals Recept. 1999; 8:32-40.
15. Brydon L, Petit L, Delagrange P, Strosber AD, Jockers R. Functional expression of MT2 (Mel 1b) melatonin receptors in human PAZ6 adipocytes. Endocrinology. 2001; 142:4264-4271.
16. Blask DE, Sauer LA, Dauchy RT. Melatonin as a chronobiotic/anticancer agent: cellular, biochemical, and molecular mechanisms of action and their implications for circadian-based cancer therapy. Curr Top Med Chem. 2002; 2:113-132.
17. Laughton C. Measurement of the specific lipid content of attached cells in microtiter cultures. Anal Biochem. 1986; 156:307-314.
18. Rivara S, Lorenzi S, Mor M, Plazzi PV, Spadoni G, Bedini A, Tarzia G. Analysis of structure-activity relationships for MT2 selective anagonists by melatonin MT1 and MT2 receptor models. J Med Chem. 2005; 48:4049-4060.
19. Roberts SB. A review of age-related changes in energy regulation and suggested mechanisms. Mech Ageing Dev. 2000; 116:157-167.
20. Labib M. The investigation and management of obesity. J Clin. Pathol. 2003; 56:17-25.
21. Roberts SB, Fuss P, Heyman MB, Evans WJ, Tsay R, Rasmussen H, Fiatarone M, Cortiella J, Dallal GE, Young VR. Control of food intake in older men. Jama. 1994; 272:1601-1606.
22. Roberts SB, Dallal GE. Energy requirements and aging. Public Health Nutr. 2005; 8:1028-1036.
23. Howarth NC, Huang TT, Roberts SB, McCrory MA. Dietary fiber and fat are associated with excess weight in young and middle-aged US adults. J Am Diet Assoc. 2005; 105:1365-1372.
24. Nelson RJ, Demas GE. Role of Melatonin in mediating seasonal energetic and immunologic adaptations. Brain Research Bolletin. 1997; 4:423-430.
25. Bairlein F. How to get fat: nutritional mechanisms of seaseonal fat acumulation in migratori songbirds. Naturwissenschaften. 2002; 89:1-10.
26. Puchalski SS, Green JN, Rasmussen DD. Melatonin effect on rat body weight regulation in response to high-fat diet at middle age. Endocrine. 2003; 21:163-167.
27. Alonso-Vale MI, Andreotti S, Peres SB, Anhe GF, das Neves Borges-Silva C, Neto JC, Lima FB. Melatonin enhances leptin expresión by rat adipocytes in the presence of insulin. Am J Physiol Endocrinol Metab. 2005; 288:805-812.
28. Mustone AM, Nieminen P, Hyvarinen H. Effects of continous light and melatonin treatment on energy metabolism of the rat. J Endocrinol Invest. 2002; 25:716-723.
29. Mustonen AM, Pyykonen T, Asikainen J, Hanninen S, Monosen J, Nieminen P. Circannual Leptin and Ghrelin Levels of the Blue Fox (Alopex lagopus) in Reference to Seasonal Rhythms of Body Mass, Adiposity, and Food Intake. Journal of Experimental zoology. 2005; 303:26-36.
30. Saarela S, Reiter RJ. Function of melatonin in thermoregulatory processes. Life Sci. 1994; 54:295-311.
31. Magri F, Sarra S, Cinchetti W, Guazzoni V, Fioravanti M, Cravello L, Ferrari E. Qualitative and quantitative changes of melatonin levels in physiological and pathological aging and in centenarians. J Pineal Research. 2004; 36:256-261.
32. Graham D, McLachlan A. Declining melatonin levels and older people. How old is old?. 2004; 25:415-418.
33. Garau C, Aparicio S, Rial RV, Nicolau MC, Esteban S. Age related changes in the activity-rest circadian rhythms and c-fos expression of ring doves with aging. Effects of tryptophan intake. Exp Gerontol. 2006; 41:430-438.
34. Graham D, McLachlan A. Declining melatonin levels and older people. How old is old?. Neuro Endocrinol Lett. 2004; 25:415-418.
35. Borges-Silva,CN, Alonso-Vale MI, Franzói-De-Moraes SM, Takada J, Peres SB, Andreotti S, Skoupa AL, Cipolla-Neto J, Pithon-Curi TC, Lima FB. Pinealectomy impairs adipose tissue adaptability to exercise in rats. J Pineal Res. 2005; 38:278-283.
36. Rasmussen DD, Boldt B, Wilkinson ChW, Yellow S, Matsumoto A. Daily melatonin administration at middle age suppresses male rat visceral fat, plasma leptin, and plasma insulin to youthful levels. Endocrinology. 1999; 2:1009-1012.
37. Derlacz RA, Poplawski P, Napierala M, Jagielski AK, Bryla J. Melatonin-induced modulation of glucose metabolism in primary cultures of rabbit kidney-cortex tubules. J Pineal Res. 2005; 38:164-169.
38. Inui A, Meguid MM. Cachexia and obesity: two sides of one coin?. Curr Opin Clin Nutr Metb. 2003; 6:395-399.
39. Mustonen A-M, Nieminen P, Asikainen J, Saarela S, Kukkonen JVK, Hyvärinen H. Continuous melatonin treatment and fasting in the raccoon dog (Nyctereutes procyonoides) - vernal body weight regulation and reproduction. Zool Sci. 2004; 21: 163-172.
40. Ng TB, Wong CM. Effects of pineal indoles and arginina vasotocin on lipolysis and lipogenesis in isolated adipocytes. J Pineal Res. 1986; 3:55-66.
41. Muller-Wieland D, Behnke B, Koopmann K, Krone W. Melatonin inhibits LDL receptor activity and cholesterol synthesis in freshly isolated human mononuclear leukocytes. Biochem Biophys Res Commun. 1994; 203:416-421.
42. Prunet-Marcassus B, Desbazeille M, Bros A, Louche K, Delagrange P, Renard P, Casteilla L, Penicaud L. Melatonin reduced body weight gain in Sprague Dawley rats with diet-induced obesity. Endocrinology. 2003; 144:5347-5352.
43. Wolden-Hanson T, Mitton DR, McCants RL, Yellon SM, Wilkinson CW, Matsumoto AM, Rasmussen DD. Daily melatonin administration to middle-aged male rats suppresses body weight, intraabdominal adiposity, and plasma leptin and insulin independent of food intake and total body fat. Endocrinology. 2000; 141:487-497.
44. Delagrange P. and Jockers R. Melatonin and energy homeostasis: peripheral versus central regulation. Endocrinol. 2003; 4:313-320.
45. Ekmekcioglu C. Melatonin receptor in humans: biological role and clinical relevance. Biomed Pharmacother. 2006; 60:97-108.
46. Lissoni P, Paolorossi F, Ardizzoia A, Barni S, Chilelli M, Mancuso M, Tancini G, Conti A, Maestroni GJ. A randomized study of chemotherapy with cisplatin plus etoposide versus chemoendocrine therapy with cisplatin, etoposide and the pineal hormone melatonin as a first-line treatment of advanced non-small cell lung cancer patients in poor clinical state. J Pineal Res. 1997; 23:15-19.
47. Mattox TW. Treatment of unintentional weight loss in patients with cancer. Nutr Clin Pract. 2005; 20:400-410.
48. Mahmoud F, Sarhill N, Mazurczak MA. The therapeutic application of melatonin in supportive care and palliative medicine. Am J Hosp Palliat Care. 2005; 22:295-309.
49. Wanke C. Pathogenesis and Consequenses of HIV-Associated Wasting. J Acquir Immune Defic Syndr. 2004; 37:277-279.
50. Faintuch J, Soeters PB, Osmo HG. Nutritional and metabolic abnormalities in pre-AIDS HIV infection. Nutrition. 2006; 22:683-690.
51. Canpolat S, Sandal S, Yilmaz B, Yasar A, Kutlu S, Baydas G, Kelestimur H. Effects of pinealectomy and exogenous melatonin on serum leptin levels in male rat. Eur J Pharmacol. 2001; 428:145-148.
52. Lissoni P, Barni S, Tancini G, Brivio F, Tisi E, Zubelewicz B, Braczkowski R. Role of the pineal gland in the control of macrophage functions and its possible implication in cancer: a study of interactions between tumor necrosis factor-alpha and the pineal hormone melatonin. 1994; 8:126-129.
53. Lissoni P, Paolorossi F, Tancini G, Barni S, Ardizzoia A, Brivio F, Zubelewicz B, Chatikhine V. Is there a role for melatonin in the treatment of neoplastic cachexia?. Eur J Cancer. 1996; 32:1340-1343.